Having an approved China Drug Master File (DMF) streamlines the regulatory process, ensuring compliance with Chinese pharmaceutical standards. It enhances market access, fosters trust with local partners, and protects proprietary information. Additionally, it facilitates faster product approvals, reduces regulatory hurdles, and strengthens competitive positioning in China’s growing pharmaceutical market.
